《全日總結》恆指升596點 科網、手機及藥股漲 小米彈6%
阿思達克 05-20 16:25
人行LPR改制後首度將五年期LPR單獨減息15點子，引發市場憧憬內地更多穩經濟措施，加上美股道指期貨在亞洲時段升近300點，港股顯著造好。恆指高開350點後升幅反覆擴大，曾升673點一度高見20,794點，全日升596點或2.97%，收20,717點；國指升221點或3.22%，收7,121點；恆生科技指數升193點或4.74%，收4,284點。大市全日成交總額1,226.68億元，滬、深港通南下交易分別淨流入7.59億及9.89億元人民幣。
科技股造好，市場憧憬小米(01810.HK)業績改善，小米升6%報11.74元，騰訊(00700.HK)升3.5%報352.2元，阿里巴巴(09988.HK)升5.6%報88.05元，美團(03690.HK)升4.5%報173元。京東(09618.HK)股價升5.9%報211.6元。百度(09888.HK)及網易(09999.HK)各升5.2%及5.1%。萬國數據(09698.HK)及嗶哩嗶哩(09626.HK)各升9.6%及6.8%，京東健康(06618.HK)、阿里健康(00241.HK)、金蝶(00268.HK)、快手(01024.HK)及商湯(00020.HK)各升5%至5.7%。
手機相關股造好，舜宇(02382.HK)、鴻騰(06088.HK)及富智康(02038.HK)各升6.9%至7.5%，瑞聲(02018.HK)升5.9%，汽車股蔚來(09866.HK)及小鵬(09868.HK)各升9.5%及7%，理想(02015.HK)及比亞迪(01211.HK)各升4%及3.5%。
醫藥股上升，康希諾(06185.HK)旗下新冠疫苗獲納入WHO緊急使用清單，股價升9.8%。信達生物(01801.HK)及藥明生物(02269.HK)各升5.3%及7.9%，石藥(01093.HK)、復星醫藥(02196.HK)、國藥(01099.HK)及中生製藥(01177.HK)各升3%至3.9%。藥明康德(02359.HK)升5.9%，券商早前報告料該股或被納入藍籌。
金融股造好，匯控(00005.HK)升1.9%報48.45元，港交所(00388.HK)升1.5%報336元，友邦(01299.HK)升4.2%報80.85元，招行(03968.HK)升7.3%報49.1元，中國平安(02318.HK)升3.2%報48.5元。
波羅的海乾散貨指數升至五個月高，中遠海控(01919.HK)升5.8%。油價上升，中石化(00386.HK)、中石油(00857.HK)及中海油(00883.HK)各升2%至3%。國務院總理李克強指今年要堅決杜絕拉閘限電，煤炭股兗礦能源(01171.HK)及中煤能源(01898.HK)各升7.6%及6.1%，神華(01088.HK)升3.4%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
